provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market. Description: Where is the largest and fastest growing market for the biologics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global biologics market opportunities and strategies to 2030 report answers all these questions and many more.
New York, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery" - https://www.reportlinker.com/p06001237/?utm_source=GNW
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration, by drug classification, and by mode of purchase.
Market Characteristics – The market characteristics section of the report defines and explains the biologics market. This chapter includes different products and services covered in the report and basic definitions.
Supply Chain – The supply chain section of the report defines and explains the key players in the biologics market supply chain.
Product Analysis – The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
Customer Information– This chapters covers recent customers’ trends/preferences in the global biologics market.
Trends And Strategies – This chapter describes the major trends shaping the global biologics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the biologics market.
Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
Market Segmentation – This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
Competitive Landscape – This section covers details on the competitive landscape of the global biologics market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research.This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets.
It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global biologics market is segmented into -
By Type: Therapeutic Proteins; Monoclonal Antibodies ((MAbS); Vaccines
Therapeutic Proteins are further segmented into- Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins
Monoclonal Antibodies (MAbS) are further segmented into- Anti-Cancer MABS; Immunological MABS; Anti-Infective Monoclonal Antibodies (MABS); Neuropharmacological Mabs; Cardiovascular And Cerebrovascular MABS; Others - Monoclonal Antibodies (MABS)
Vaccines are further segmented into- Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines
By Route Of Administration: Oral; Others (IV and IP)
By Drug Classification: Branded Drugs; Generic Drugs
By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson
Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics information.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Gain a global perspective on the development of the market.
Read the full report: https://www.reportlinker.com/p06001237/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001